(Q37730611)

22 August 2017

Use of adjuvant sorafenib in liver transplant recipients with high-risk hepatocellular carcinoma (English)

1 reference

22 August 2017

Kirti Shetty

1

1 reference

PMCID

4003738

22 August 2017

Chiranjeev Dash

series ordinal

2

1 reference

PMCID

4003738

22 August 2017

Jacqueline Laurin

series ordinal

3

1 reference

22 August 2017

10 April 2014

1 reference

Journal of transplantation

22 August 2017

1 reference

22 August 2017

2014

1 reference

22 August 2017

913634

1 reference

Creative Commons Attribution 3.0 Unported

22 August 2017

start time

1 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

23 August 2017

Hepatocellular carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Hepatocellular carcinoma: agents and concepts for preventing recurrence after curative treatment

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Sorafenib in advanced hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Treating hepatocellular carcinoma with sorafenib in liver transplant patients: an initial experience

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Sorafenib for recurrence of hepatocellular carcinoma after liver transplantation.

23 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Efficacy and safety of sorafenib in combination with mammalian target of rapamycin inhibitors for recurrent hepatocellular carcinoma after liver transplantation.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4003738

Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies

1 September 2018

1 reference

12 December 2020

mTOR inhibitors and sorafenib for recurrent heptocellular carcinoma after orthotopic liver transplantation

1 reference

12 December 2020

Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters

1 reference

12 December 2020

Potential impact of sorafenib on the survival benefit of liver transplantation for hepatocellular carcinoma

1 reference

12 December 2020

Identifiers

DOI

10.1155/2014/913634

1 reference

22 August 2017

1 reference

22 August 2017

1 reference

PMCID

4003738